Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Colorectal Neoplasms 93Stomach Neoplasms 56Rectal Neoplasms 51Colonic Neoplasms 47Pancreatic Neoplasms 20Neoplasms 14Carcinoma, Hepatocellular 14Neoplasm Metastasis 13Adenocarcinoma 10Parkinson Disease 4, Autosomal Dominant Lewy Body 9Lymphoma, Large B-Cell, Diffuse 9Cholangiocarcinoma 8Adenocarcinoma Of Esophagus 8Esophageal Neoplasms 5Biliary Tract Neoplasms 5Neurotoxicity Syndromes 4Esophageal Squamous Cell Carcinoma 4Lymphoma, Extranodal NK-T-Cell 3Gastrointestinal Neoplasms 3Gallbladder Neoplasms 3Peritoneal Neoplasms 2Lymphoma 2Liver Neoplasms 2Hepatoblastoma 2Gastrointestinal Diseases 2Colorectal Adenocarcinoma 2Testicular Neoplasms 1Testicular Germ Cell Tumor 1Teratoma 1Spinocerebellar Degenerations 1

Interventions

Cyclophosphamide 5Vincristine 4Prednisolone 3Methotrexate 3Doxorubicin 3Cytarabine 3pegfilgrastim 2Radiotherapy 2Prednisone 2Peripheral Blood Stem Cell Transplantation 2Mercaptopurine 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Etoposide 2Early Intervention, Educational 2liposomal amphotericin B 1glutamic acid diethyl ester 1aldesleukin 1Vancomycin 1Valacyclovir 1Thioguanine 1Therapeutics 1Tazobactam 1Rituximab 1Ribavirin 1Psychiatric Rehabilitation 1Piperacillin, Tazobactam Drug Combination 1Piperacillin 1Palivizumab 1Oxaliplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Dendritic Cell Sarcoma, Interdigitating × Oxaliplatin × Clear all
NCT07570823 2026-05-06

A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Gemcitabine and Oxaliplatin in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Sinocelltech Ltd.

Phase 3 Not yet recruiting
101 enrolled
Sarcoma

Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡